The reason was that we had what we needed. You're right—there was mRNA hesitancy, but we had non-mRNA options that were already on the table. Actually, that's a success of the advance purchase agreement we did, because that way we not only had mRNA, but we had non-mRNA options. At that point in time, Canada had the vaccines it needed, and it meant that we didn't need to proceed with Medicago. Therefore, that was the right decision.
On December 6th, 2023. See this statement in context.